← Nazad


Ardanaz E



Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer. 2017;77:140-52. [Šekerija M]

Autori: Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larranaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R, EUROCARE-5 Working Group
Godina: 2017

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017;18(8):1022-39.[Šekerija M]

Autori: Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A, RARECAREnet working group
Godina: 2017

(Šekerija M) Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study. European journal of cancer. 2015.

Autori: Crocetti E, Mallone S, Robsahm TE, Gavin A, Agius D, Ardanaz E
Godina: 2015

(Šekerija M) Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study. European Journal of Cancer. 2015.

Autori: Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK
Godina: 2015

(Šekerija M) Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. European Journal of Cancer. 2015.

Autori: Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P
Godina: 2015